Improving Federal Oversight of HHS Grantees

The US Department of Health and Human Services considers ways to mitigate the risk of poor performance or misuse of funds by grantees.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

IMAGE, PUBLICDOMAINPICTURESThe US federal department that awards more than $400 billion in grants to researchers every year is seeking ways to better oversee funding recipients. The key to this, according to a report released this week (September 2) by the Department of Health and Human Services’s (HHS) Office of the Inspector General (OIG), is better information sharing among 13 HHS awarding agencies, including the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). Such an improvement could help funders identify and deal with researchers who underperform or misuse grant money. “Awarding agencies’ grant officials use various sources of information and communication to mitigate grantee risks; however, grant officials noted limitations in some instances,” the report read.

In surveying grant officials at different HHS agencies, the OIG found that reports reviewed to mitigate the risk of grant misuse are often late and incomplete, identified lapses in communication between grant management officers, and uncovered a failure of some agencies to submit National External Audit Review Center memoranda. It also found that fewer than half of the HHS awarding agencies share information about grantees with other agencies.

In its report, the OIG recommended that funding agencies improve their use of databases designed to monitor grantees, establish a department-wide repository for adverse information from audits of grantees, and enhance information sharing across HHS.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio